Company intelligence / Profile preview

Cann

Brooklyn, New York, United States

Ownership: Private
Employees: ~82
Development stage: Other

Overview

Cann is a private U.S. cannabis beverage company that sells low-dose THC- and CBD-infused social tonics positioned as alcohol alternatives. The business markets microdosed, non-alcoholic drinks under the Cann brand, along with higher-dose Hi Boy products and portable Roadie formats. Its products emphasize fast-onset, sessionable cannabis consumption for adult-use social and wellness occasions rather than prescription therapeutics. Cann appears to operate as an active, venture-backed consumer cannabis company rather than a traditional biotech or pharmaceutical developer.

Therapeutic areas: PsychiatryOther
Modalities: Non-pharmacological therapy
Industry: Food & Nutrition

Beyond the preview

Go deeper on Cann.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cann.

Explore the full profile